Risk factors for drug-induced parkinsonism in tardive dyskinesia patients

Thomas Hansen, W. L. Brown, R. M. Weigel, Daniel Casey

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Using multivariate stiatistical analyses, the authors identified risk factors for development of drug-induced parkinsonism (DIP) in 66 tardive dyskinesia (TD) patients. Older age, recent use of neuroleptics, shorter duration of past neuroleptic exposure, and severity of TD were associated with increased risk of DIP. The clinician should devise treatment strategies in anticipation of the occurrence of DIP regardless of the presence or absence of TD, especially in older patients. New models for the pathophysiology of the two disorders are needed.

Original languageEnglish (US)
Pages (from-to)139-141
Number of pages3
JournalJournal of Clinical Psychiatry
Volume49
Issue number4
StatePublished - 1988
Externally publishedYes

Fingerprint

Parkinsonian Disorders
Antipsychotic Agents
Pharmaceutical Preparations
Multivariate Analysis
Tardive Dyskinesia
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Risk factors for drug-induced parkinsonism in tardive dyskinesia patients. / Hansen, Thomas; Brown, W. L.; Weigel, R. M.; Casey, Daniel.

In: Journal of Clinical Psychiatry, Vol. 49, No. 4, 1988, p. 139-141.

Research output: Contribution to journalArticle

Hansen, T, Brown, WL, Weigel, RM & Casey, D 1988, 'Risk factors for drug-induced parkinsonism in tardive dyskinesia patients', Journal of Clinical Psychiatry, vol. 49, no. 4, pp. 139-141.
Hansen, Thomas ; Brown, W. L. ; Weigel, R. M. ; Casey, Daniel. / Risk factors for drug-induced parkinsonism in tardive dyskinesia patients. In: Journal of Clinical Psychiatry. 1988 ; Vol. 49, No. 4. pp. 139-141.
@article{2b292624db9f4a45a9bbf74bd4764cd2,
title = "Risk factors for drug-induced parkinsonism in tardive dyskinesia patients",
abstract = "Using multivariate stiatistical analyses, the authors identified risk factors for development of drug-induced parkinsonism (DIP) in 66 tardive dyskinesia (TD) patients. Older age, recent use of neuroleptics, shorter duration of past neuroleptic exposure, and severity of TD were associated with increased risk of DIP. The clinician should devise treatment strategies in anticipation of the occurrence of DIP regardless of the presence or absence of TD, especially in older patients. New models for the pathophysiology of the two disorders are needed.",
author = "Thomas Hansen and Brown, {W. L.} and Weigel, {R. M.} and Daniel Casey",
year = "1988",
language = "English (US)",
volume = "49",
pages = "139--141",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "4",

}

TY - JOUR

T1 - Risk factors for drug-induced parkinsonism in tardive dyskinesia patients

AU - Hansen, Thomas

AU - Brown, W. L.

AU - Weigel, R. M.

AU - Casey, Daniel

PY - 1988

Y1 - 1988

N2 - Using multivariate stiatistical analyses, the authors identified risk factors for development of drug-induced parkinsonism (DIP) in 66 tardive dyskinesia (TD) patients. Older age, recent use of neuroleptics, shorter duration of past neuroleptic exposure, and severity of TD were associated with increased risk of DIP. The clinician should devise treatment strategies in anticipation of the occurrence of DIP regardless of the presence or absence of TD, especially in older patients. New models for the pathophysiology of the two disorders are needed.

AB - Using multivariate stiatistical analyses, the authors identified risk factors for development of drug-induced parkinsonism (DIP) in 66 tardive dyskinesia (TD) patients. Older age, recent use of neuroleptics, shorter duration of past neuroleptic exposure, and severity of TD were associated with increased risk of DIP. The clinician should devise treatment strategies in anticipation of the occurrence of DIP regardless of the presence or absence of TD, especially in older patients. New models for the pathophysiology of the two disorders are needed.

UR - http://www.scopus.com/inward/record.url?scp=0023940233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023940233&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 139

EP - 141

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 4

ER -